JP2022551067A5 - - Google Patents

Info

Publication number
JP2022551067A5
JP2022551067A5 JP2022520063A JP2022520063A JP2022551067A5 JP 2022551067 A5 JP2022551067 A5 JP 2022551067A5 JP 2022520063 A JP2022520063 A JP 2022520063A JP 2022520063 A JP2022520063 A JP 2022520063A JP 2022551067 A5 JP2022551067 A5 JP 2022551067A5
Authority
JP
Japan
Prior art keywords
alkyl
hydroxy
benzo
pentyl
chromen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022520063A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022551067A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051328 external-priority patent/WO2021062557A1/en
Publication of JP2022551067A publication Critical patent/JP2022551067A/ja
Publication of JP2022551067A5 publication Critical patent/JP2022551067A5/ja
Pending legal-status Critical Current

Links

JP2022520063A 2019-10-02 2020-10-02 カンナビノイド誘導体 Pending JP2022551067A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962909370P 2019-10-02 2019-10-02
US62/909,370 2019-10-02
PCT/CA2020/051328 WO2021062557A1 (en) 2019-10-02 2020-10-02 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2022551067A JP2022551067A (ja) 2022-12-07
JP2022551067A5 true JP2022551067A5 (enExample) 2023-10-11

Family

ID=75336679

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022520063A Pending JP2022551067A (ja) 2019-10-02 2020-10-02 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20220340582A1 (enExample)
EP (1) EP4038058A4 (enExample)
JP (1) JP2022551067A (enExample)
WO (1) WO2021062557A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3994114A4 (en) 2019-07-04 2023-08-16 Canopy Growth Corporation CANNABINOID DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
WO2021007661A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12084407B2 (en) 2019-11-26 2024-09-10 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12617765B2 (en) 2019-12-09 2026-05-05 Canopy Growth Corporation Cannabinoid derivatives
IL312785B2 (en) 2020-05-19 2026-06-01 Cybin Irl Ltd Deuterated tryptamine derivatives and methods of use
AU2021400338A1 (en) 2020-12-17 2023-07-13 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use
US12091396B1 (en) * 2021-10-07 2024-09-17 Adam Woodson System and method for reacting one or more compounds to form tetrahydrocannabinolic acid (THCA)
US20250019345A1 (en) * 2021-11-10 2025-01-16 London Pharmaceuticals And Research Corporation New cannabinoid-gabapentinoid conjugates and uses thereof
EP4434975A4 (en) * 2021-11-16 2025-11-05 K Medichem Co Ltd NEW CANABICHROMENIC ACID DERIVATIVE, ASSOCIATED PREPARATION PROCESS, AND COMPOSITION COMPRISING THEREOF INTENDED TO IMPROVE COGNITIVE FUNCTION
WO2024192324A2 (en) * 2023-03-15 2024-09-19 Berkowitz Barry A Analogs of cannabichromene and cannabichromenic acid and process of preparing
US12636296B1 (en) 2025-07-17 2026-05-26 Nalu Bio, Inc. Cannabinol analogs and their use as pharmacologically active agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080064679A1 (en) * 2004-06-24 2008-03-13 Martin Billy R Water Soluble Cannabinoids
WO2014039042A1 (en) * 2012-09-06 2014-03-13 Northeastern University Novel cannabinergic compounds and uses thereof
US9580400B2 (en) * 2013-02-26 2017-02-28 Northeastern University Cannabinergic nitrate esters and related analogs
WO2019234728A1 (en) * 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof
WO2021007659A1 (en) * 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives

Similar Documents

Publication Publication Date Title
JP2022551066A5 (enExample)
JP2022540434A5 (enExample)
JP2022539400A5 (enExample)
JP2023503601A5 (enExample)
JP2023503330A5 (enExample)
JP2022540432A5 (enExample)
JP2022540585A5 (enExample)
JP2022539401A5 (enExample)
JP5373405B2 (ja) 選択的アンドロゲン受容体モジュレーター
JP2022540586A5 (enExample)
KR102664618B1 (ko) 사치환된 알켄 화합물 및 그의 용도
ES2590929T3 (es) Derivados de bencilsulfonamida útiles como inhibidores de MOGAT-2
ES2960991T3 (es) Benzoimidazol-1,2-ilamidas como activadores del canal Kv7
JP2024533216A (ja) インドール化合物及び使用方法
JP2022540433A5 (enExample)
JP2013514356A (ja) ピロロ[2,3−d]ピリミジン化合物
AR074184A1 (es) Compuestos de 7-azaspiro[3.5]nonano-7-carboxamida, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de afecciones mediadas por la inhibicion de faah
IL287159B2 (en) Small molecules agonists for FXR (farnesoid X receptor) and method for their preparation and use
WO2008150492A1 (en) Tricyclic inhibitors of fatty acid amide hydrolase
JP2011500818A5 (enExample)
EP2809661B1 (en) Novel morpholinyl derivatives useful as mogat-2 inhibitors
JP2010509334A5 (enExample)
JP2011511053A (ja) ボリノスタットの新規な製造方法
US7034015B2 (en) Aminobenzoephenones
CN1337947A (zh) 炔基磺酰胺硫醇tace抑制剂